Enter assignee name

% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 18

Loading Chart...

15 inventors (with patents filed for the assignee):

Jeroen Cunera Verheijen (2 out of 15 patents)

Nadia M J Rupniak (2 out of 2 patents)

Shoucheng Du (2 out of 2 patents)

4. James F White (2 out of 42 patents)

5. Brigida Allieri (1 out of 1 patent)

6. Paul Fagan (1 out of 1 patent)

7. Emma Sharp (1 out of 11 patents)

8. Raymond D Skwierczynski (1 out of 20 patents)

9. Jonathan Cummins (1 out of 4 patents)

10. Jean-Francois Carniaux (1 out of 5 patents)

11. Daniel Coughlin (1 out of 7 patents)

12. Kazumi Shiosaki (1 out of 8 patents)

13. ShouCheng Du (1 out of 1 patent)

14. J David Leander (1 out of 3 patents)

15. Alison Pilgrim (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12257246 - Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl[-benzamide (2025-03-25),

2. 11053214 - Compositions and methods related to pyridinoylpiperidine 5-HTagonists (2021-07-06),

3. 8697876 - Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists (2014-04-15),

4. 8101782 - Compounds that inhibit cholinesterase (2012-01-24),

5. 7897639 - Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents (2011-03-01),

6. 7795307 - Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents (2010-09-14),

Colucid Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of migraine. With a commitment to improving the lives of migraine sufferers, Colucid is dedicated to advancing its pipeline of promising drug candidates through rigorous research and development. The company's cutting-edge approach and experienced team make it a leader in the field of migraine therapeutics.

Profile summary based on public USPTO records.